Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Anglo-French Drugs & Industries Limited, is an unlisted public company incorporated on 01 February, 1923. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 2.00 cr and the total paid-up capital is INR 1.23 cr.
Anglo-French Drugs & Industries Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 606.36% over the previous year. At the same time, it's book networth has increased by 1032.45%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 30.0 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 13.7 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 0.1 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Abhay Kanoria | 00108894 | 28 years |
Whole-time Director | Uddhav Abhay Kanoria | 00108909 | 18 years |
Whole-time Director | Nirbhay Abhay Kanoria | 02558300 | 0 years |
Director | Pradeep Joshi | 02713934 | 1 years |
Director | Rohit Choraria | 07003583 | 2 years |
Director | Rakesh Parmeshwar Kanyadi | 08532438 | 5 years |
Director | Srinivasan Krishnan | 08709528 | 1 years |
Director | Rani Shokeen | 10634071 | 0 years |
Kmp | Manee Sriee Aneetha | <HIDDEN> | 2 years |
Kmp | Manik Kumar Singh | <HIDDEN> | 0 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
BROACH TEXTILE MILLS LIMITED (FULLFLEDGED PUBLIC CO ) |
Active
|
8.9 Cr | 2 | Maharashtra |
RADHA KESARI SPINNING MILLS LIMITED |
Active
|
8.5 L | 1 | Gujarat |
SUDARSHAN EXPORTS LTD |
Strike Off
|
49.5 L | 1 | West Bengal |
THAMES LINERS LTD |
Strike Off
|
24.5 L | 1 | West Bengal |
BROACH PROCESSORS PVT LTD |
Amalgamated
|
50.5 L | 2 | Maharashtra |
TIRUPATI PRINTERS PVT LTD |
Amalgamated
|
50.5 L | 2 | Maharashtra |
SUDARSHAN EXPORTS LIMITED |
Active
|
32.8 L | 2 | Maharashtra |
EKTA TIE-UP PRIVATE LIMITED |
Active
|
1.6 Cr | 2 | Maharashtra |
SHRI BINOD KANORIA FOUNDATION |
Active
|
10,000.0 | 2 | Maharashtra |
PARITOSH INDUSTRIAL FINANCE LIMITED |
Amalgamated
|
50.0 L | 1 | Maharashtra |
ENTREPRENEURS' ORGANIZATION MUMBAI |
Active
|
0.0 | 1 | Maharashtra |
AFD PHARMA PRIVATE LIMITED |
Active
|
17.0 L | 1 | Maharashtra |
BALA MANDIR FOUNDATION |
Active
|
0.0 | 1 | Tamil Nadu |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Anglo French Drugs & Industries Pte. Ltd. | Singapore | - | - |
The incorporation date of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is 01 February, 1923
The authorized share capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is INR ₹ 2.0 Cr.
The paid-up capital of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is INR ₹ 1.2 Cr.
The registered address of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is Plot No.4 Phase II, Peenya Industrial Area, Peenya Peenya Sm all Industries Bangalore North Bangalore Karnataka - 560058
The CIN number of ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED is L24230KA1923PLC010205.